38746889|t|Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment.
38746889|a|The potassium (K+) ion channel KCNK13 is specifically expressed in human microglia with elevated expression observed in post-mortem human brain tissue from patients with Alzheimer's disease. Modulation of KCNK13 activity by a small-molecule inhibitor is proposed as a potential treatment for neurodegenerative diseases. Herein, we describe the evolution of a series of KCNK13 inhibitors derived from a high-throughput screening campaign, resulting in CVN293, a potent, selective, and brain permeable clinical candidate molecule. CVN293 demonstrated a concentration-dependent inhibition of the NLRP3-inflammasome mediated production of IL-1beta from LPS-primed murine microglia. Cross-species pharmacokinetic data of CVN293 are also disclosed. These findings support the advancement of CVN293 in clinical trials.
38746889	39	45	KCNK13	Gene	56659
38746889	47	53	THIK-1	Gene	56659
38746889	103	112	potassium	Chemical	MESH:D011188
38746889	114	116	K+	Chemical	MESH:D011188
38746889	130	136	KCNK13	Gene	56659
38746889	166	171	human	Species	9606
38746889	231	236	human	Species	9606
38746889	255	263	patients	Species	9606
38746889	269	288	Alzheimer's disease	Disease	MESH:D000544
38746889	304	310	KCNK13	Gene	56659
38746889	391	417	neurodegenerative diseases	Disease	MESH:D019636
38746889	468	474	KCNK13	Gene	56659
38746889	550	556	CVN293	Chemical	-
38746889	628	634	CVN293	Chemical	-
38746889	692	697	NLRP3	Gene	216799
38746889	734	742	IL-1beta	Gene	16176
38746889	748	751	LPS	Chemical	MESH:D008070
38746889	759	765	murine	Species	10090
38746889	815	821	CVN293	Chemical	-
38746889	Association	MESH:D000544	56659
38746889	Association	16176	216799
38746889	Association	MESH:D019636	56659

